DK0883616T3 - Dihydrobenzofuranforbindelser og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler - Google Patents
Dihydrobenzofuranforbindelser og beslægtede forbindelser, der er nyttige som antiinflammatoriske midlerInfo
- Publication number
- DK0883616T3 DK0883616T3 DK97904018T DK97904018T DK0883616T3 DK 0883616 T3 DK0883616 T3 DK 0883616T3 DK 97904018 T DK97904018 T DK 97904018T DK 97904018 T DK97904018 T DK 97904018T DK 0883616 T3 DK0883616 T3 DK 0883616T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- hydrogen
- atoms
- inflammatory agents
- dihydrobenzofuran
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/595,087 US5821250A (en) | 1996-02-01 | 1996-02-01 | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
EP97904018A EP0883616B1 (fr) | 1996-02-01 | 1997-01-30 | Dihydrobenzorfurane et composes apparentes utilises comme agents anti-inflammatoires |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0883616T3 true DK0883616T3 (da) | 2004-11-01 |
Family
ID=24381679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97904018T DK0883616T3 (da) | 1996-02-01 | 1997-01-30 | Dihydrobenzofuranforbindelser og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler |
Country Status (15)
Country | Link |
---|---|
US (3) | US5821250A (fr) |
EP (1) | EP0883616B1 (fr) |
JP (1) | JP3202245B2 (fr) |
KR (1) | KR100322401B1 (fr) |
CN (1) | CN1109679C (fr) |
AT (1) | ATE274506T1 (fr) |
AU (1) | AU730264B2 (fr) |
BR (1) | BR9707333A (fr) |
CA (1) | CA2244411A1 (fr) |
DE (1) | DE69730415T2 (fr) |
DK (1) | DK0883616T3 (fr) |
ES (1) | ES2229332T3 (fr) |
MX (1) | MX9806248A (fr) |
NO (1) | NO983529L (fr) |
WO (1) | WO1997028146A1 (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
DE19548708A1 (de) * | 1995-12-23 | 1997-06-26 | Merck Patent Gmbh | Cyclische Sulfone |
AU753576B2 (en) * | 1997-12-15 | 2002-10-24 | Altana Pharma Ag | Dihydrobenzofurans |
US6667299B1 (en) * | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
ATE445838T1 (de) | 2001-07-25 | 2009-10-15 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
US7235249B2 (en) | 2002-03-28 | 2007-06-26 | The Procter & Gamble Company | Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions |
US7098189B2 (en) * | 2002-12-16 | 2006-08-29 | Kimberly-Clark Worldwide, Inc. | Wound and skin care compositions |
US20050003024A1 (en) * | 2003-03-04 | 2005-01-06 | The Procter & Gamble Company | Regulation of mammalian hair growth |
US20050255059A1 (en) * | 2004-05-10 | 2005-11-17 | Oblong John E | Personal care compositions and methods regulating mammalian hair growth |
US20050255060A1 (en) * | 2004-05-10 | 2005-11-17 | Oblong John E | Personal care compositions and methods regulating mammalian hair growth |
US7485666B2 (en) * | 2004-06-17 | 2009-02-03 | Kimberly-Clark Worldwide, Inc. | Vaginal health products |
US20060269508A1 (en) * | 2005-03-29 | 2006-11-30 | Trejo Amy V | Means for regulating the cosmetic appearance and/or health of human keratinous tissue |
US9616011B2 (en) | 2005-04-27 | 2017-04-11 | The Procter & Gamble Company | Personal care compositions |
US20080095732A1 (en) * | 2005-04-27 | 2008-04-24 | Rosemarie Osborne | Personal care compositions |
US20070020220A1 (en) * | 2005-04-27 | 2007-01-25 | Procter & Gamble | Personal care compositions |
EP2671508B1 (fr) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Système pharma-informatique |
US20070020221A1 (en) * | 2005-05-17 | 2007-01-25 | Bissett Donald L | Regulation of mammalian keratinous tissue using personal care compositions comprising cetyl pyridinium chloride |
US20060263321A1 (en) * | 2005-05-17 | 2006-11-23 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using personal care compositions comprising diethylhexyl syringylidene malonate |
WO2007041548A2 (fr) * | 2005-09-30 | 2007-04-12 | The Procter & Gamble Company | Regulation d'un tissu keratinise d'un mammifere par des substances actives pour les soins de la peau |
CA2876767C (fr) | 2005-10-03 | 2018-07-10 | Mark A. Pinsky | Liposomes contenant de l'acide hyaluronique et leur utilisation dans l'amelioration des soins de la peau |
US20070134173A1 (en) * | 2005-12-09 | 2007-06-14 | The Procter & Gamble Company | Personal care compositions |
US20070196296A1 (en) * | 2005-12-13 | 2007-08-23 | Rosemarie Osborne | Personal care compositions |
WO2007070523A2 (fr) * | 2005-12-13 | 2007-06-21 | The Procter & Gamble Company | Compositions pour soins personnels |
US20070203240A1 (en) * | 2006-02-27 | 2007-08-30 | The Procter & Gamble Company | Personal care compositions and methods for regulating mammalian hair growth |
US20080027575A1 (en) * | 2006-04-21 | 2008-01-31 | Jones Stevan D | Modeling systems for health and beauty consumer goods |
CA2663377A1 (fr) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Traitement des troubles hepatiques par l'administration de conjugues de proteine associee au recepteur (rap) |
CN100475189C (zh) | 2006-10-17 | 2009-04-08 | 王海龙 | 一种化妆品组合物及其制备方法和应用 |
KR101269393B1 (ko) | 2008-04-28 | 2013-05-29 | 아사히 가세이 파마 가부시키가이샤 | 페닐프로피온산 유도체 및 이의 용도 |
US9676696B2 (en) | 2009-01-29 | 2017-06-13 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
HUE059078T2 (hu) | 2009-02-20 | 2022-10-28 | Enhanx Biopharm Inc | Glutation-alapú hatóanyagszállító rendszer |
JP2012526144A (ja) | 2009-05-06 | 2012-10-25 | ラボラトリー スキン ケア インコーポレイテッド | 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法 |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
US8986677B2 (en) | 2012-07-30 | 2015-03-24 | Pop Test Cortisol Llc | Therapeutic compositions and methods |
US9241891B2 (en) | 2012-10-30 | 2016-01-26 | The Procter & Gamble Company | Personal care compositions comprising self-assembling peptides |
EP3080142B1 (fr) | 2013-12-10 | 2018-01-31 | Sussex Research Laboratories Inc. | Compositions glycopeptidiques et leurs utilisations |
WO2018067520A2 (fr) | 2016-10-04 | 2018-04-12 | Pop Test Oncology Llc | Procédés et agents thérapeutiques |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6019305B2 (ja) * | 1976-07-02 | 1985-05-15 | ウェルファイド株式会社 | ジヒドロベンゾフラン誘導体 |
IT1093805B (it) * | 1978-01-31 | 1985-07-26 | Erba Carlo Spa | Derivati del 2h-benzofuran-3-one e procedimento per la loro preparazione |
US4533734A (en) * | 1983-11-10 | 1985-08-06 | Eli Lilly And Company | Inotropic agents |
US4849428A (en) * | 1987-11-23 | 1989-07-18 | The Procter & Gamble Company | Cyclic anti-inflammatory derivatives of di-tert-butylphenol compounds, compositions and use |
JP2808460B2 (ja) * | 1989-11-16 | 1998-10-08 | 大正製薬株式会社 | イミダゾール誘導体 |
JPH03215485A (ja) * | 1990-01-11 | 1991-09-20 | Taisho Pharmaceut Co Ltd | ベンゾチエニルイミダゾール誘導体 |
CN1191243C (zh) * | 1994-07-27 | 2005-03-02 | 范德比尔特大学 | 用作抗炎剂的二氢苯并呋喃和相关化合物 |
US5684002A (en) * | 1994-09-07 | 1997-11-04 | The Procter & Gamble Company | Dihydorbenzofuran and related compounds useful as anti-inflammatory agents |
-
1996
- 1996-02-01 US US08/595,087 patent/US5821250A/en not_active Expired - Fee Related
-
1997
- 1997-01-30 BR BR9707333A patent/BR9707333A/pt not_active Application Discontinuation
- 1997-01-30 DE DE1997630415 patent/DE69730415T2/de not_active Expired - Fee Related
- 1997-01-30 KR KR1019980705949A patent/KR100322401B1/ko not_active IP Right Cessation
- 1997-01-30 CA CA002244411A patent/CA2244411A1/fr not_active Abandoned
- 1997-01-30 CN CN97192019A patent/CN1109679C/zh not_active Expired - Fee Related
- 1997-01-30 JP JP52776197A patent/JP3202245B2/ja not_active Expired - Fee Related
- 1997-01-30 DK DK97904018T patent/DK0883616T3/da active
- 1997-01-30 AT AT97904018T patent/ATE274506T1/de not_active IP Right Cessation
- 1997-01-30 EP EP97904018A patent/EP0883616B1/fr not_active Expired - Lifetime
- 1997-01-30 WO PCT/US1997/001313 patent/WO1997028146A1/fr active IP Right Grant
- 1997-01-30 ES ES97904018T patent/ES2229332T3/es not_active Expired - Lifetime
- 1997-01-30 AU AU18432/97A patent/AU730264B2/en not_active Ceased
-
1998
- 1998-04-09 US US09/058,405 patent/US5972957A/en not_active Expired - Lifetime
- 1998-04-09 US US09/057,686 patent/US5981547A/en not_active Expired - Lifetime
- 1998-07-31 NO NO983529A patent/NO983529L/no not_active Application Discontinuation
- 1998-08-03 MX MX9806248A patent/MX9806248A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU1843297A (en) | 1997-08-22 |
CN1109679C (zh) | 2003-05-28 |
NO983529D0 (no) | 1998-07-31 |
BR9707333A (pt) | 1999-07-20 |
CN1210531A (zh) | 1999-03-10 |
KR19990082221A (ko) | 1999-11-25 |
US5972957A (en) | 1999-10-26 |
KR100322401B1 (ko) | 2002-05-09 |
US5981547A (en) | 1999-11-09 |
DE69730415D1 (de) | 2004-09-30 |
EP0883616A1 (fr) | 1998-12-16 |
DE69730415T2 (de) | 2005-01-13 |
ATE274506T1 (de) | 2004-09-15 |
JP3202245B2 (ja) | 2001-08-27 |
ES2229332T3 (es) | 2005-04-16 |
JPH11503469A (ja) | 1999-03-26 |
EP0883616B1 (fr) | 2004-08-25 |
NO983529L (no) | 1998-09-28 |
US5821250A (en) | 1998-10-13 |
MX9806248A (es) | 1998-11-30 |
CA2244411A1 (fr) | 1997-08-07 |
AU730264B2 (en) | 2001-03-01 |
WO1997028146A1 (fr) | 1997-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0883616T3 (da) | Dihydrobenzofuranforbindelser og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler | |
DK0779886T3 (da) | Dihydrobenzofuran og beslægtede forbindelser, der er anvendelige som antiinflammatoriske midler | |
NO985679D0 (no) | Dihydrobenzopyran og beslektede forbindelser nyttige som anti-inflammasjonsmidler | |
DK0879231T3 (da) | Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler | |
DK0891346T3 (da) | Dihydrobenzofuranforbindelser, der er nyttige som antiinflammatoriske midler | |
MX9806247A (es) | Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios. | |
DK0904270T3 (da) | Dihydrobenzofuran og beslægtede forbindelser anvendelige som antiinflammatoriske midler | |
DK0904272T3 (da) | Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler | |
CA2244245A1 (fr) | Composes de dihydrobenzofurane utilise comme agents anti-inflammatoires |